Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER.

Guglielmo Mariani, MD, Mariasanta Napolitano, MD, Alberto Dolce, PhD, Marie Bertrand, MD, Pimlak Charoenkwan, MD, Dragan Micic, Maria Fernanda López Fernández, MD, Arlette Ruiz de Saez, Sergio Siragusa, MD, Jorgen Ingerslev

Blood (2012) 120 (21): 2279.

https://doi.org/10.1182/blood.V120.21.2279.2279

Published: 2012

Journal Articles

Pharmacokinetics of Factor VII

Massimo Morfini, Uriel Martinowitz, Angelika Batorova, MD, PhD, Alberto Dolce, PhD, Mariasanta Napolitano, MD, Jorgen Ingerslev, Jean-Francois Schved, Guglielmo Mariani, MD

Blood (2011) 118 (21): 2259.

https://doi.org/10.1182/blood.V118.21.2259.2259

Published: 2011

Journal Articles

Management of the Sponataneous Bleeding Episodes in Factor VII Deficiency. A Prospective Evaluation of the STER,

Blood (2011) 118 (21): 3368.

https://doi.org/10.1182/blood.V118.21.3368.3368

Published: 2011

Journal Articles

Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience

Blood (2011) 118 (21): 1262.

https://doi.org/10.1182/blood.V118.21.1262.1262

Published: 2011

Journal Articles

At Disease Presentation, Severity of the Bleeding Symptom Predicts the Following Bleeds in Patients with FVII Deficiency

Matteo ND Di Minno, Angelika Batorova, MD, PhD, Mariasanta Napolitano, MD, Alberto Dolce, PhD, Giovanni Di Minno, MD, Francesco Bernardi, PhD, Jean-Francois Schved, Jørgen Ingerslev, MD, Muriel Giansily-Blaizot, MD, PhD, Guenter K.H. Auerswald, Sr., MD, Guglielmo Mariani, MD

Blood (2011) 118 (21): 30.

https://doi.org/10.1182/blood.V118.21.30.30

Published: 2011

Journal Articles

Prophylaxis In Congenital Factor VII Deficiency, Indications, Efficacy and Safety: Results of the STER

Mariasanta Napolitano, MD, Muriel Giansily-Blaizot, MD, PhD, Alberto Dolce, PhD, Jens Bierre Knudsen, PhD, Jean-Francois Schved, MD, PhD, Guenter Auerswald, MD, Jorgen Ingerslev, MD, Tahir S Shamsi, MD, Carmen Altisent, MD, Pimlak Chararoenkwan, MD, Lisa Michaels, MD, Ampaiwan Chuansumrit, MD, Giovanni di Minno, MD, Umran Caliskan, MD, Guglielmo Mariani, MD

Blood (2010) 116 (21): 665.

https://doi.org/10.1182/blood.V116.21.665.665

Published: 2010

Journal Articles

Replacement Therapy for Surgery in FVII Deficiency: The Ster Experience Concerning 63 Interventions.

Guglielmo Mariani, MD, Angelika Batorova, MD, Alberto Dolce, PhD, Sergio Siragusa, MD, Mario Lapecorella, MD, Jens Bierre Knudsen, MD, Giovanni Di Minno, MD, Elvira Grandone, MD, Giuseppe Tagariello, MD, AnnaRita Tagliaferri, MD, Guenter K.H. K.H. Auerswald, Sr., MD, Jørgen Ingerslev, MD

Blood (2009) 114 (22): 1290.

https://doi.org/10.1182/blood.V114.22.1290.1290

Published: 2009

Journal Articles

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study

Sergio Siragusa, Alessandra Malato, Raffaela Anastasio, Valeria Cigna, Glauco Milio, Corrado Amato, Mario Bellisi, Maria Teresa Attanzio, Oreste Cormaci, Massimo Pellegrino, Alberto Dolce, Alessandra Casuccio, Guido Bajardi, Guglielmo Mariani

Blood (2008) 112 (3): 511–515.

https://doi.org/10.1182/blood-2008-01-131656

Published: 2008

Journal Articles

Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients

Vanesa Caruso, Licia Iacoviello, Augusto Di Castelnuovo, Sergio Storti, Guglielmo Mariani, Giovanni de Gaetano, Maria Benedetta Donati

Blood (2006) 108 (7): 2216–2222.

https://doi.org/10.1182/blood-2006-04-015511

Published: 2006

Journal Articles

Thrombotic Complications in Acute Lymphoblastic Leukemia. A Meta-Analysis of Prospective Studies Comprising 1,920 Patients.

Vanesa Caruso, MD, Augusto Di Castelnuovo, PhySc, Sergio Storti, MD, Guglielmo Mariani, MD, Licia Iacoviello, MD, M. Benedetta Donati, MD

Blood (2005) 106 (11): 2153.

https://doi.org/10.1182/blood.V106.11.2153.2153

Published: 2005

Journal Articles

Objective Assessment of Pulmonary Embolism Can Be Deferred without Increased Risk.

Sergio Siragusa, MD, Alessandra Malato, MD, Antonino Giarratano, MD, Francesco Falaschi, MD, Fernando Porro, MD, Maria Cristina Buonanno, MD, Elena Maggi, MD, Raffaela Anastasio, MD, Lucio Lo Coco, Guglielmo Mariani, MD

Blood (2005) 106 (11): 1628.

https://doi.org/10.1182/blood.V106.11.1628.1628

Published: 2005

Journal Articles

Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up

Blood (2002) 100 (9): 3141–3146.

https://doi.org/10.1182/blood-2002-02-0352

Published: 2002

Journal Articles

Residual factor VII activity and different hemorrhagic phenotypes in CRM + factor VII deficiencies (Gly331Ser and Gly283Ser)

Mirko Pinotti, Daniela Etro, Debora Bindini, Maria Luisa Papa, Giuseppina Rodorigo, Angiola Rocino, Guglielmo Mariani, Nicola Ciavarella, Francesco Bernardi

Blood (2002) 99 (4): 1495–1497.

https://doi.org/10.1182/blood.V99.4.1495

Published: 2002

Journal Articles

Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7)

Guglielmo Mariani, Falko H. Herrmann, Francesco Bernardi, Jean-Francois Schved, Gunther Auerswald, Jorgen Ingerslev, The Factor VII Deficiency Study Group

Blood (2000) 96 (1): 374.

https://doi.org/10.1182/blood.V96.1.374

Published: 2000

NARROW

Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER.

Pharmacokinetics of Factor VII

Management of the Sponataneous Bleeding Episodes in Factor VII Deficiency. A Prospective Evaluation of the STER,

Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience

At Disease Presentation, Severity of the Bleeding Symptom Predicts the Following Bleeds in Patients with FVII Deficiency

Prophylaxis In Congenital Factor VII Deficiency, Indications, Efficacy and Safety: Results of the STER

Replacement Therapy for Surgery in FVII Deficiency: The Ster Experience Concerning 63 Interventions.

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study

Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients

Thrombotic Complications in Acute Lymphoblastic Leukemia. A Meta-Analysis of Prospective Studies Comprising 1,920 Patients.

Objective Assessment of Pulmonary Embolism Can Be Deferred without Increased Risk.

Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up

Residual factor VII activity and different hemorrhagic phenotypes in CRM + factor VII deficiencies (Gly331Ser and Gly283Ser)

Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only